Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. clarity

Clarity SIGNED

Real-time renal diagnostic to prevent ICU-acquired Acute Kidney Injury (AKI).

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Clarity project word cloud

Explore the words cloud of the Clarity project. It provides you a very rough idea of what is the project "Clarity" about.

data    clinical    flow    consistent    staff    decade    24    fluid    time    prevent    strategy    renalsense    die    basis    provides    trials    organisation    sensor    outcomes    nursing    intensive    showed    people    plan    market    treatment    medical    introduces    industrialization    days    worldwide    rms    pittsburgh    gbd    tested    trade    limit    rapid    urine    transmitting    burden    disease    monitoring    feasible    hospital    patient    variably    lost    significantly    automatically    million    sign    practiced    hadassah    electronic    morbidity    57    clarity    icu    kidney    accurate    herzog    renal    balance    function    requiring    unfortunately    ing    records    intervention    invaluable    interprets    patients    serious    13    acquired    develops    therapy    patented    curative    efficacy    risk    care    critical    hours    mortality    acute    fluctuations    prevention    university    volume    aki    secured    changing    injury    additional    alerts    composition    prevalent    facilitates    global    reflects    feasibility   

Project "Clarity" data sheet

The following table provides information about the project.

Coordinator		 RENAL SENSE LTD 

Organization address
address: HAMARPE 3
city: JERUSALEM
postcode: 91450
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Israel [IL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2020-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    RENAL SENSE LTD IL (JERUSALEM) coordinator 50˙000.00

Map

 Project objective

Intensive Care Unit (ICU)-acquired Acute Kidney Injury (AKI) is a prevalent and serious problem, associated with significantly increased morbidity and mortality. According to the Global Burden of Disease (GBD), each year around 1.7 million people worldwide are estimated to die from AKI. AKI develops in over 57% of ICU patients, requiring an average of 3.5 additional hospital days and €13,000 of additional hospital costs per patient. The best treatment for AKI is prevention. Although there is no curative therapy for AKI, research over the past decade identified various means to prevent or limit AKI. Unfortunately, these are not widely known and are variably practiced worldwide resulting in lost opportunities to improve the care and outcomes of patients with AKI. RenalSense introduces Clarity RMS™, a critical care monitoring system that continuously measures urine flow, automatically transmitting to the medical staff real-time data and alerts of fluctuations, on a 24/7 basis. Using patented sensor technology, Clarity measures, analyses and interprets the continuously changing composition and flow volume of urine. This information, which reflects changes in renal function, provides an early sign of AKI risk and facilitates rapid intervention. In addition, it is invaluable for monitoring treatment efficacy and managing fluid balance. The system has been tested during clinical trials with Herzog hospital, Hadassah Medical Organisation and University of Pittsburgh. Analysis of 1,000 study hours showed that electronic measurements with Clarity were more consistent, reliable and accurate than nursing records. During the feasibility assessment, RenalSense will establish a go-to-market strategy, as well as a feasible product development plan and industrialization strategy. The plan for the large-scale clinical trials will be defined, and the participants secured.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLARITY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLARITY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

CAARESYS (2019)

CAARESYS: vehicle passenger monitoring system based on contactless low emission radio frequency radar.

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More